Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS).
Taggart
David P
DP
Neubauer
Stefan
S
D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic; D015897:Comorbidity; D001026:Coronary Artery Bypass / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000201:enzymology* / Q000401:mortality / Q000601:surgery; D003402:Creatine Kinase / Q000032:analysis; D052279:Creatine Kinase, MB Form; D006801:Humans; D015994:Incidence; D007527:Isoenzymes / Q000032:analysis; D018482:Muscle, Skeletal / Q000098:blood supply / Q000201:enzymology; D009203:Myocardial Infarction / Q000453:epidemiology; D009204:Myocardial Revascularization / Q000009:adverse effects; D009206:Myocardium / Q000201:enzymology*; D011237:Predictive Value of Tests; D011379:Prognosis; D012008:Recurrence; D012306:Risk; D012680:Sensitivity and Specificity
D015415:Biomarkers; D007527:Isoenzymes; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form